{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:22:26Z","timestamp":1794374546056,"version":"4.9.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/S021930\/1"],"award-info":[{"award-number":["EP\/S021930\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/N021967\/1"],"award-info":[{"award-number":["EP\/N021967\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/R006032\/1"],"award-info":[{"award-number":["EP\/R006032\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000771","name":"Prostate Cancer UK","doi-asserted-by":"publisher","award":["PG14-018-TR2"],"award-info":[{"award-number":["PG14-018-TR2"]}],"id":[{"id":"10.13039\/501100000771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Noninvasive microstructure estimates using magnetic resonance imaging (MRI) show potential in improving prostate cancer (PCa) diagnosis; however, histological validation is necessary.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      We used data from the Histo-MRI trial (NCT04792138). Participants with biopsy-confirmed PCa underwent multiparametric (mp) MRI and \u201cvascular, extracellular, and restricted diffusion for cytometry in tumors\u201d (VERDICT)-MRI before radical prostatectomy. Personalized molds enabled matching prostatectomy histology with corresponding VERDICT-MRI images. Comparisons between histological epithelial cell density measures and MRI were made on a region-of-interest (ROI) basis using Pearson correlation coefficient (\n                      <jats:italic>r<\/jats:italic>\n                      ) with 95% confidence interval (CI). Differences between benign tissue and clinically significant PCa were analyzed using the area under the receiver operating characteristic curve (AUC).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty-two participants, aged 65\u2009\u00b1\u20096 years (mean\u2009\u00b1\u2009standard deviation), with Gleason grade\u2009\u2265\u20093\u2009+\u20094, were included. ROI analysis showed stronger correlations of VERDICT fractional intracellular volume (fIC) with epithelial fraction, epithelial cell density, and cell density (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.784 [0.70, 0.84], 0.747 [0.66, 0.81], 0.711 [0.60, 0.79] than VERDICT ADC (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009-0.639 [-0.54, -0.71], -0.609 [-0.51, -0.69], -0.587 [-0.45, -0.69]), or mpMRI ADC (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009-0.357 [-0.18, -0.51], -0.315 [-0.15, -0.46], -0.266 [-0.08, -0.43]), respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). VERDICT fIC showed similar differences between benign and clinically significant PCa (0.16\u2009\u00b1\u20090.10 to 0.51\u2009\u00b1\u20090.13, AUC\u2009=\u20090.99,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) to epithelial fraction (0.21\u2009\u00b1\u20090.08 to 0.43\u2009\u00b1\u20090.12, AUC\u2009=\u20090.94,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>VERDICT fIC showed clinical potential as a biomarker of epithelial cell density.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>\n                              <jats:italic>Question<\/jats:italic>\n                            <\/jats:bold>\n                            Can VERDICT-MRI fIC provide a biologically interpretable, noninvasive imaging biomarker of epithelial cell density in the prostate?\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>\n                              <jats:italic>Findings<\/jats:italic>\n                            <\/jats:bold>\n                            VERDICT fIC showed stronger correlations with histological epithelial fraction, cell density, and epithelial density than both VERDICT-derived ADC and mpMRI ADC.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>\n                              <jats:italic>Relevance statement<\/jats:italic>\n                            <\/jats:bold>\n                            These findings support\n                            <jats:italic>in vivo<\/jats:italic>\n                            VERDICT fIC as a noninvasive biomarker of prostate epithelial microstructure and show promise for wider clinical use, improving the detection rate of clinically significant PCa, reducing unnecessary biopsies, and allowing better risk stratification.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41747-026-00797-w","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:41:49Z","timestamp":1788946909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Validating the biological origin of in vivo fractional intracellular volume from VERDICT-MRI in the prostate"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3129-8948","authenticated-orcid":false,"given":"Marta","family":"Masramon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomy","family":"Mertzanidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Retter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Thorley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianti-Vasiliki","family":"Papoutsaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Grussu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeru","family":"Kasivisvanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Grey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin","family":"Dinneen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Caselton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shonit","family":"Punwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Panagiotaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"797_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815\u2013822. https:\/\/doi.org\/10.1016\/S0140-6736(16)32401-1","journal-title":"Lancet"},{"key":"797_CR2","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.3390\/cancers14143497","volume":"14","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Simpson BS, Morka N et al (2022) Comparison of multiparametric magnetic resonance imaging with prostate-specific membrane antigen positron-emission tomography imaging in primary prostate cancer diagnosis: a systematic review and meta-analysis. Cancers (Basel) 14:3497. https:\/\/doi.org\/10.3390\/cancers14143497","journal-title":"Cancers (Basel)"},{"key":"797_CR3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","volume":"78","author":"NJ Sathianathen","year":"2020","unstructured":"Sathianathen NJ, Omer A, Harriss E et al (2020) Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data system era: a systematic review and meta-analysis. Eur Urol 78:402\u2013414. https:\/\/doi.org\/10.1016\/j.eururo.2020.03.048","journal-title":"Eur Urol"},{"key":"797_CR4","doi-asserted-by":"crossref","unstructured":"Epstein JI, Cubilla AL, Humphrey PA (2011) Tumors of the prostate gland, seminal vesicles, penis, and scrotum. American Registry of Pathology, Washington, DC","DOI":"10.55418\/9781933477145"},{"key":"797_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1148\/radiol.2016152542","volume":"280","author":"AB Rosenkrantz","year":"2016","unstructured":"Rosenkrantz AB, Ginocchio LA, Cornfeld D et al (2016) Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists. Radiology 280:793\u2013804. https:\/\/doi.org\/10.1148\/radiol.2016152542","journal-title":"Radiology"},{"key":"797_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1148\/radiol.2020190646","volume":"296","author":"AC Westphalen","year":"2020","unstructured":"Westphalen AC, McCulloch CE, Anaokar JM et al (2020) Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the Society of Abdominal Radiology prostate cancer disease-focused panel. Radiology 296:76\u201384. https:\/\/doi.org\/10.1148\/radiol.2020190646","journal-title":"Radiology"},{"key":"797_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1053\/j.sult.2021.07.006","volume":"42","author":"E Martinez-Heras","year":"2021","unstructured":"Martinez-Heras E, Grussu F, Prados F, Solana E, Llufriu S (2021) Diffusion-weighted imaging: Recent advances and applications. Semin Ultrasound CT MR 42:490\u2013506. https:\/\/doi.org\/10.1053\/j.sult.2021.07.006","journal-title":"Semin Ultrasound CT MR"},{"key":"797_CR8","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1158\/0008-5472.CAN-13-2511","volume":"74","author":"E Panagiotaki","year":"2014","unstructured":"Panagiotaki E, Walker-Samuel S, Siow B et al (2014) Noninvasive quantification of solid tumor microstructure using VERDICT MRI. Cancer Res 74:1902\u20131912. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2511","journal-title":"Cancer Res"},{"key":"797_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4019","volume":"32","author":"E Bonet-Carne","year":"2019","unstructured":"Bonet-Carne E, Johnston E, Daducci A et al (2019) VERDICT-AMICO: Ultrafast fitting algorithm for non-invasive prostate microstructure characterization. NMR Biomed 32:e4019. https:\/\/doi.org\/10.1002\/nbm.4019","journal-title":"NMR Biomed"},{"key":"797_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1148\/radiol.2019181749","volume":"291","author":"EW Johnston","year":"2019","unstructured":"Johnston EW, Bonet-Carne E, Ferizi U et al (2019) VERDICT MRI for prostate cancer: intracellular volume fraction versus apparent diffusion coefficient. Radiology 291:391\u2013397. https:\/\/doi.org\/10.1148\/radiol.2019181749","journal-title":"Radiology"},{"key":"797_CR11","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3390\/cancers13081985","volume":"13","author":"H Pye","year":"2021","unstructured":"Pye H, Singh S, Norris JM et al (2021) Evaluation of PSA and PSA density in a multiparametric magnetic resonance imaging-directed diagnostic pathway for suspected prostate cancer: the INNOVATE trial. Cancers (Basel) 13:1985. https:\/\/doi.org\/10.3390\/cancers13081985","journal-title":"Cancers (Basel)"},{"key":"797_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1148\/radiol.212536","volume":"305","author":"S Singh","year":"2022","unstructured":"Singh S, Rogers H, Kanber B et al (2022) Avoiding unnecessary biopsy after multiparametric prostate MRI with VERDICT analysis: The INNOVATE study. Radiology 305:623\u2013630. https:\/\/doi.org\/10.1148\/radiol.212536","journal-title":"Radiology"},{"key":"797_CR13","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3390\/diagnostics12071631","volume":"12","author":"S Sen","year":"2022","unstructured":"Sen S, Valindria V, Slator PJ et al (2022) Differentiating false positive lesions from clinically significant cancer and normal prostate tissue using VERDICT MRI and other diffusion models. Diagnostics (Basel) 12:1631. https:\/\/doi.org\/10.3390\/diagnostics12071631","journal-title":"Diagnostics (Basel)"},{"key":"797_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30182-1","volume":"13","author":"M Palombo","year":"2023","unstructured":"Palombo M, Valindria V, Singh S et al (2023) Joint estimation of relaxation and diffusion tissue parameters for prostate cancer with relaxation-VERDICT MRI. Sci Rep 13:29999. https:\/\/doi.org\/10.1038\/s41598-023-30182-1","journal-title":"Sci Rep"},{"key":"797_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.110782","volume":"162","author":"HJ Rogers","year":"2023","unstructured":"Rogers HJ, Singh S, Barnes A et al (2023) Test-retest repeatability of ADC in prostate using the multi b-value VERDICT acquisition. Eur J Radiol 162:110782. https:\/\/doi.org\/10.1016\/j.ejrad.2023.110782","journal-title":"Eur J Radiol"},{"key":"797_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.111109","volume":"168","author":"S Singh","year":"2023","unstructured":"Singh S, Giganti F, Dickinson L et al (2023) Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefacts. Eur J Radiol 168:111109. https:\/\/doi.org\/10.1016\/j.ejrad.2023.111109","journal-title":"Eur J Radiol"},{"key":"797_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/bju.15998","volume":"132","author":"J Morote","year":"2023","unstructured":"Morote J, Pye H, Campistol M et al (2023) Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging. BJU Int 132:188\u2013195. https:\/\/doi.org\/10.1111\/bju.15998","journal-title":"BJU Int"},{"key":"797_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/path.6152","volume":"261","author":"E Scott","year":"2023","unstructured":"Scott E, Archer Goode E, Garnham R et al (2023) ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression. J Pathol 261:71\u201384. https:\/\/doi.org\/10.1002\/path.6152","journal-title":"J Pathol"},{"key":"797_CR19","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1002\/mrm.30186","volume":"92","author":"S Sen","year":"2024","unstructured":"Sen S, Singh S, Pye H et al (2024) ssVERDICT: self-supervised VERDICT-MRI for enhanced prostate tumor characterization. Magn Reson Med 92:2181\u20132192. https:\/\/doi.org\/10.1002\/mrm.30186","journal-title":"Magn Reson Med"},{"key":"797_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2856-2","volume":"16","author":"E Johnston","year":"2016","unstructured":"Johnston E, Pye H, Bonet-Carne E et al (2016) INNOVATE: a prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer. BMC Cancer 16:816. https:\/\/doi.org\/10.1186\/s12885-016-2856-2","journal-title":"BMC Cancer"},{"key":"797_CR21","doi-asserted-by":"publisher","first-page":"e059847","DOI":"10.1136\/bmjopen-2021-059847","volume":"12","author":"S Singh","year":"2022","unstructured":"Singh S, Mathew M, Mertzanidou T et al (2022) Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancer. BMJ Open 12:e059847. https:\/\/doi.org\/10.1136\/bmjopen-2021-059847","journal-title":"BMJ Open"},{"key":"797_CR22","unstructured":"Clunie DA (2020) DicomCleaner (PixelMed Toolkit) [computer software]. PixelMed Publishing. https:\/\/www.dclunie.com\/pixelmed\/software\/index.html"},{"key":"797_CR23","unstructured":"Horos Project (2023) Horos (Version 4.0.0) [computer software]. Nimble Co LLC (Purview), Annapolis. https:\/\/horosproject.org"},{"key":"797_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fonc.2017.00047","volume":"7","author":"RM Bourne","year":"2017","unstructured":"Bourne RM, Bailey C, Johnston EW et al (2017) Apparatus for histological validation of in vivo and ex vivo magnetic resonance imaging of the human prostate. Front Oncol 7:47. https:\/\/doi.org\/10.3389\/fonc.2017.00047","journal-title":"Front Oncol"},{"key":"797_CR25","unstructured":"Oxley J, Colling R, Manohar V, Mitchard J (2024) Standards and datasets for reporting cancers: dataset for histopathology reports for prostatic carcinoma (G084, Version 4). Royal College of Pathologists, London"},{"key":"797_CR26","unstructured":"MIM Software Inc. (2024) MIM (Version 7.2.9) [computer software]. MIM Software Inc., Cleveland. https:\/\/www.mimsoftware.com"},{"key":"797_CR27","unstructured":"Suvarna K, Layton C, Bancroft J (eds) (2019) Bancroft\u2019s theory and practice of histological techniques, 8th edn. Elsevier, Oxford"},{"key":"797_CR28","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1097\/00000478-199612000-00009","volume":"20","author":"AR Schned","year":"1996","unstructured":"Schned AR, Wheeler KJ, Hodorowski CA et al (1996) Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol 20:1501\u20131506. https:\/\/doi.org\/10.1097\/00000478-199612000-00009","journal-title":"Am J Surg Pathol"},{"key":"797_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00428-006-0259-5","volume":"449","author":"S Jonmarker","year":"2006","unstructured":"Jonmarker S, Valdman A, Lindberg A, Hellstr\u00f6m M, Egevad L (2006) Tissue shrinkage after fixation with formalin injection of prostatectomy specimens. Virchows Arch 449:297\u2013301. https:\/\/doi.org\/10.1007\/s00428-006-0259-5","journal-title":"Virchows Arch"},{"key":"797_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7:16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5","journal-title":"Sci Rep"},{"key":"797_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1148\/radiol.2015142414","volume":"277","author":"A Chatterjee","year":"2015","unstructured":"Chatterjee A, Watson G, Myint E, Sved P, McEntee M, Bourne R (2015) Changes in epithelium, stroma, and lumen space correlate more strongly with Gleason pattern and are stronger predictors of prostate ADC changes than cellularity metrics. Radiology 277:751\u2013762. https:\/\/doi.org\/10.1148\/radiol.2015142414","journal-title":"Radiology"},{"key":"797_CR32","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/RLI.0b013e3181b4c10e","volume":"44","author":"P Gibbs","year":"2009","unstructured":"Gibbs P, Liney GP, Pickles MD, Zelhof B, Rodrigues G, Turnbull LW (2009) Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol 44:572\u2013576. https:\/\/doi.org\/10.1097\/RLI.0b013e3181b4c10e","journal-title":"Invest Radiol"},{"key":"797_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1464-410X.2008.08130.x","volume":"103","author":"B Zelhof","year":"2009","unstructured":"Zelhof B, Pickles M, Liney G et al (2009) Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int 103:883\u2013888. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.08130.x","journal-title":"BJU Int"},{"key":"797_CR34","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s00261-016-0942-1","volume":"42","author":"DI Glazer","year":"2017","unstructured":"Glazer DI, Hassanzadeh E, Fedorov A et al (2017) Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology. Abdom Radiol (NY) 42:918\u2013925. https:\/\/doi.org\/10.1007\/s00261-016-0942-1","journal-title":"Abdom Radiol (NY)"},{"key":"797_CR35","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/jmri.21797","volume":"29","author":"ZW Xi","year":"2009","unstructured":"Xi ZW, Wang B, Zhi QG et al (2009) Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation. J Magn Reson Imaging 29:1360\u20131366. https:\/\/doi.org\/10.1002\/jmri.21797","journal-title":"J Magn Reson Imaging"},{"key":"797_CR36","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.1016\/j.crad.2014.06.012","volume":"69","author":"C Orczyk","year":"2014","unstructured":"Orczyk C, Taneja SS, Rusinek H, Rosenkrantz AB (2014) Assessment of change in prostate volume and shape following surgical resection through co-registration of in-vivo MRI and fresh specimen ex-vivo MRI. Clin Radiol 69:e398\u2013e403. https:\/\/doi.org\/10.1016\/j.crad.2014.06.012","journal-title":"Clin Radiol"},{"key":"797_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.5229","volume":"37","author":"M Molendowska","year":"2024","unstructured":"Molendowska M, Palombo M, Foley KG et al (2024) Diffusion MRI in prostate cancer with ultra-strong whole-body gradients. NMR Biomed 37:e5229. https:\/\/doi.org\/10.1002\/nbm.5229","journal-title":"NMR Biomed"},{"key":"797_CR38","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210842","volume":"95","author":"N Sushentsev","year":"2022","unstructured":"Sushentsev N, Caglic I, Rundo L et al (2022) Serial changes in tumour measurements and apparent diffusion coefficients in prostate cancer patients on active surveillance with and without histopathological progression. Br J Radiol 95:20210842. https:\/\/doi.org\/10.1259\/bjr.20210842","journal-title":"Br J Radiol"},{"key":"797_CR39","doi-asserted-by":"publisher","first-page":"620","DOI":"10.2214\/AJR.17.17790","volume":"209","author":"VA Morgan","year":"2017","unstructured":"Morgan VA, Parker C, MacDonald A, Thomas K, deSouza NM (2017) Monitoring tumor volume in patients with prostate cancer undergoing active surveillance: Is MRI apparent diffusion coefficient indicative of tumor growth? AJR Am J Roentgenol 209:620\u2013628. https:\/\/doi.org\/10.2214\/AJR.17.17790","journal-title":"AJR Am J Roentgenol"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-026-00797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41747-026-00797-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-026-00797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:41:53Z","timestamp":1788946913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41747-026-00797-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["797"],"URL":"https:\/\/doi.org\/10.1186\/s41747-026-00797-w","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this prospective study was granted by the London-Queen Square Research Ethics Committee (19\/LO\/1803) on 23 January 2020. All screened participants were provided with Participant Information Leaflets detailing the study's objectives and their involvement; those interested provided informed written consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of this manuscript declare relationships with the following companies: Qubim (SP), NVision (SP), Gold Standard Phantoms (SP), Angle plc. (GS), Sonablate (AG), AngioDynamics (AG), HC21\/Aquilant (AG), Docus AI (SS), and Queen Square Analytics (DA).","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"123"}}